Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- SPEC.ST
- Price
- 1.76
- Stock movement down
- -0.05 (-2.77%)
- Company name
- SpectraCure AB
- Exchange
- (ST ,
- Currency
- SEK )
- Sector
- Healthcare >Medical Devices
- Market cap
- 170.76M
- Ent value
- 158.17M
- Price/Sales
- 29.68
- Price/Book
- 1.53
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 11.41%
- 1 year return
- -23.40%
- 3 year return
- -43.23%
- 5 year return
- -38.25%
- 10 year return
- -
Last updated: 2025-04-12
DIVIDENDS
SPEC.ST does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 29.68 |
| Price to Book | 1.53 |
| EV to Sales | 27.49 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 97.13M |
| EPS (TTM) | -0.22 |
| FCF per share (TTM) | -0.32 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 5.75M |
| Gross profit (TTM) | 6.23M |
| Operating income (TTM) | -24.80M |
| Net income (TTM) | -22.73M |
| EPS (TTM) | -0.22 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 108.34% |
| Operating margin (TTM) | -430.99% |
| Profit margin (TTM) | -395.05% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 27.82M |
| Net receivables | 0.00 |
| Total current assets | 31.21M |
| Goodwill | 0.00 |
| Intangible assets | 89.45M |
| Property, plant and equipment | 0.00 |
| Total assets | 126.73M |
| Accounts payable | 4.41M |
| Short/Current long term debt | 5.59M |
| Total current liabilities | 12.13M |
| Total liabilities | 15.23M |
| Shareholder's equity | 111.50M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -18.06M |
| Capital expenditures (TTM) | 14.94M |
| Free cash flow (TTM) | -33.00M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -20.39% |
| Return on Assets | -17.94% |
| Return on Invested Capital | -19.94% |
| Cash Return on Invested Capital | -28.95% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 1.74 |
| Daily high | 1.85 |
| Daily low | 1.74 |
| Daily Volume | 28K |
| All-time high | 43.31 |
| 1y analyst estimate | 8.26 |
| Beta | 0.71 |
| EPS (TTM) | -0.22 |
| Dividend per share | - |
| Ex-div date | 1 Sep 2022 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SPEC.ST | S&P500 | |
| Current price drop from All-time high | -95.94% | -12.89% |
| Highest price drop | -97.65% | -56.47% |
| Date of highest drop | 9 Dec 2024 | 9 Mar 2009 |
| Avg drop from high | -60.85% | -11.07% |
| Avg time to new high | 65 days | 12 days |
| Max time to new high | 1451 days | 1805 days |
COMPANY DETAILS
Marketcap
170.76M
Marketcap category
Small-cap
Description
SpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden.
Employees
13
Website
Investor relations
-
SEC filings
CEO
Country
Sweden
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
As February 2025 unfolds, the European market is marked by cautious optimism amidst ongoing geopolitical developments and trade policy shifts. Despite these uncertainties, investors continue to explor...
February 28, 2025
Global markets have been experiencing a turbulent start to the year, with U.S. equities declining amid inflation concerns and political uncertainty, while small-cap stocks underperformed their larger ...
January 14, 2025
As global markets react to recent interest rate cuts by the ECB and SNB, investors are closely watching for a potential rate cut from the Federal Reserve. In such a fluctuating market landscape, penny...
December 16, 2024
As global markets react to recent political shifts and economic policies, major indices have reached new heights, with U.S. stocks rallying on expectations of growth and tax reforms. In this context, ...
November 15, 2024